Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer

Background To evaluate outcomes of laparoscopic retroperitoneal para-aortic lymphadenectomy for stage 1b3-3b cervical cancer.Methods Pathology databases searched for all para-aortic lymphadenectomy cases 2005–2016. Descriptive statistics were used to analyse baseline characteristics, cox models for...

Full description

Saved in:
Bibliographic Details
Main Authors: Claire Newton, Radha Graham, Viola Liberale, Matthew Burnell, Usha Menon, Tim Mould, Adeola Olaitan, Nicola Macdonald, Martin Widschwendter, Kostas Doufekas, Mary McCormack, Anita Mitra, Rupali Arora, Ranjit Manchanda
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Journal of Obstetrics and Gynaecology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/01443615.2024.2344529
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841553129035792384
author Claire Newton
Radha Graham
Viola Liberale
Matthew Burnell
Usha Menon
Tim Mould
Adeola Olaitan
Nicola Macdonald
Martin Widschwendter
Kostas Doufekas
Mary McCormack
Anita Mitra
Rupali Arora
Ranjit Manchanda
author_facet Claire Newton
Radha Graham
Viola Liberale
Matthew Burnell
Usha Menon
Tim Mould
Adeola Olaitan
Nicola Macdonald
Martin Widschwendter
Kostas Doufekas
Mary McCormack
Anita Mitra
Rupali Arora
Ranjit Manchanda
author_sort Claire Newton
collection DOAJ
description Background To evaluate outcomes of laparoscopic retroperitoneal para-aortic lymphadenectomy for stage 1b3-3b cervical cancer.Methods Pathology databases searched for all para-aortic lymphadenectomy cases 2005–2016. Descriptive statistics were used to analyse baseline characteristics, cox models for treatment affect after accounting for variables, and Kaplan Meier curves for survival (STATA v15).Results 191 patients had 1b3-3b cervical cancer of which 110 patients had Para-aortic lymphadenectomy. 8 (7.3%) patients stage 1b3, 82 (74.6%) stage 2b, and 20 (18.1%) stage 3b cervical cancer. Mean lymph node count 11.7 (SD7.6). The intra-operative and post-operative 30 day complication rates were 8.8% (CI: 4.3%, 15.7%) and 5.3% (CI: 1.9%, 11.2%) respectively.Para-aortic nodes were apparently positive on CT/MRI in 5/110 (5%) cases. Cancer was found in 10 (8.9%, CI: 4.3%, 15.7%) cases on histology, all received extended field radiotherapy. Only 2 were identified on pre-operative CT/MRI imaging. 3 of 10 suspected node-positive cases on CT/MRI had negative histology. Para-aortic lymphadenectomy led to alteration in staging and radiotherapy management in 8 (8%, CI: 3.7%, 14.6%) patients. Mean overall survival 42.81 months (SD = 31.79 months). Survival was significantly higher for women undergoing PAN (50.57 (SD 30.7) months) compared to those who didn’t (31.27 (SD 32.5) months)Conclusion Laparoscopic retroperitoneal para-aortic lymphadenectomy is an acceptable procedure which can guide treatment in women with locally advanced cervical cancer.
format Article
id doaj-art-13aad1304a9a495b96a43affc1b98ef8
institution Kabale University
issn 0144-3615
1364-6893
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Journal of Obstetrics and Gynaecology
spelling doaj-art-13aad1304a9a495b96a43affc1b98ef82025-01-09T12:13:17ZengTaylor & Francis GroupJournal of Obstetrics and Gynaecology0144-36151364-68932024-12-0144110.1080/01443615.2024.2344529Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancerClaire Newton0Radha Graham1Viola Liberale2Matthew Burnell3Usha Menon4Tim Mould5Adeola Olaitan6Nicola Macdonald7Martin Widschwendter8Kostas Doufekas9Mary McCormack10Anita Mitra11Rupali Arora12Ranjit Manchanda13Gynaecology Oncology, University Hospitals Bristol NHS Foundation trust, Bristol, UKUniversity College London Hospital NHS Foundation Trust, London, UKUniversity College London Hospital NHS Foundation Trust, London, UKMRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UKMRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UKUniversity College London Hospital NHS Foundation Trust, London, UKUniversity College London Hospital NHS Foundation Trust, London, UKUniversity College London Hospital NHS Foundation Trust, London, UKUniversity College London Hospital NHS Foundation Trust, London, UKUniversity College London Hospital NHS Foundation Trust, London, UKUniversity College London Hospital NHS Foundation Trust, London, UKUniversity College London Hospital NHS Foundation Trust, London, UKUniversity College London Hospital NHS Foundation Trust, London, UKMRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UKBackground To evaluate outcomes of laparoscopic retroperitoneal para-aortic lymphadenectomy for stage 1b3-3b cervical cancer.Methods Pathology databases searched for all para-aortic lymphadenectomy cases 2005–2016. Descriptive statistics were used to analyse baseline characteristics, cox models for treatment affect after accounting for variables, and Kaplan Meier curves for survival (STATA v15).Results 191 patients had 1b3-3b cervical cancer of which 110 patients had Para-aortic lymphadenectomy. 8 (7.3%) patients stage 1b3, 82 (74.6%) stage 2b, and 20 (18.1%) stage 3b cervical cancer. Mean lymph node count 11.7 (SD7.6). The intra-operative and post-operative 30 day complication rates were 8.8% (CI: 4.3%, 15.7%) and 5.3% (CI: 1.9%, 11.2%) respectively.Para-aortic nodes were apparently positive on CT/MRI in 5/110 (5%) cases. Cancer was found in 10 (8.9%, CI: 4.3%, 15.7%) cases on histology, all received extended field radiotherapy. Only 2 were identified on pre-operative CT/MRI imaging. 3 of 10 suspected node-positive cases on CT/MRI had negative histology. Para-aortic lymphadenectomy led to alteration in staging and radiotherapy management in 8 (8%, CI: 3.7%, 14.6%) patients. Mean overall survival 42.81 months (SD = 31.79 months). Survival was significantly higher for women undergoing PAN (50.57 (SD 30.7) months) compared to those who didn’t (31.27 (SD 32.5) months)Conclusion Laparoscopic retroperitoneal para-aortic lymphadenectomy is an acceptable procedure which can guide treatment in women with locally advanced cervical cancer.https://www.tandfonline.com/doi/10.1080/01443615.2024.2344529Cervical cancerlymphadenectomy
spellingShingle Claire Newton
Radha Graham
Viola Liberale
Matthew Burnell
Usha Menon
Tim Mould
Adeola Olaitan
Nicola Macdonald
Martin Widschwendter
Kostas Doufekas
Mary McCormack
Anita Mitra
Rupali Arora
Ranjit Manchanda
Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer
Journal of Obstetrics and Gynaecology
Cervical cancer
lymphadenectomy
title Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer
title_full Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer
title_fullStr Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer
title_full_unstemmed Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer
title_short Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer
title_sort outcomes of minimal access retroperitoneal para aortic lymphadenectomy in patients with locally advanced cervical cancer
topic Cervical cancer
lymphadenectomy
url https://www.tandfonline.com/doi/10.1080/01443615.2024.2344529
work_keys_str_mv AT clairenewton outcomesofminimalaccessretroperitonealparaaorticlymphadenectomyinpatientswithlocallyadvancedcervicalcancer
AT radhagraham outcomesofminimalaccessretroperitonealparaaorticlymphadenectomyinpatientswithlocallyadvancedcervicalcancer
AT violaliberale outcomesofminimalaccessretroperitonealparaaorticlymphadenectomyinpatientswithlocallyadvancedcervicalcancer
AT matthewburnell outcomesofminimalaccessretroperitonealparaaorticlymphadenectomyinpatientswithlocallyadvancedcervicalcancer
AT ushamenon outcomesofminimalaccessretroperitonealparaaorticlymphadenectomyinpatientswithlocallyadvancedcervicalcancer
AT timmould outcomesofminimalaccessretroperitonealparaaorticlymphadenectomyinpatientswithlocallyadvancedcervicalcancer
AT adeolaolaitan outcomesofminimalaccessretroperitonealparaaorticlymphadenectomyinpatientswithlocallyadvancedcervicalcancer
AT nicolamacdonald outcomesofminimalaccessretroperitonealparaaorticlymphadenectomyinpatientswithlocallyadvancedcervicalcancer
AT martinwidschwendter outcomesofminimalaccessretroperitonealparaaorticlymphadenectomyinpatientswithlocallyadvancedcervicalcancer
AT kostasdoufekas outcomesofminimalaccessretroperitonealparaaorticlymphadenectomyinpatientswithlocallyadvancedcervicalcancer
AT marymccormack outcomesofminimalaccessretroperitonealparaaorticlymphadenectomyinpatientswithlocallyadvancedcervicalcancer
AT anitamitra outcomesofminimalaccessretroperitonealparaaorticlymphadenectomyinpatientswithlocallyadvancedcervicalcancer
AT rupaliarora outcomesofminimalaccessretroperitonealparaaorticlymphadenectomyinpatientswithlocallyadvancedcervicalcancer
AT ranjitmanchanda outcomesofminimalaccessretroperitonealparaaorticlymphadenectomyinpatientswithlocallyadvancedcervicalcancer